James Green is Chairman, President and Chief Executive Officer of Harvard Bioscience. He was named President and Chief Executive Officer in July 2019 and Chairman of the Board of Directors in June 2017. Green has been a member of the Company’s Board of Directors since April 2015. Green served as President and Chief Executive Officer of Analogic Corporation (NASDAQ: ALOG) from 2007 to 2016. While leading the public company through the great recession, Analogic’s core revenues grew over 50%, and gross margins, operating margins and earnings per share dramatically improved. Immediately prior to becoming President and Chief Executive Officer of Harvard Bioscience, Green served as President of Spacelabs Healthcare, where he led a successful global restructuring, rationalizing the company’s cost structure and product portfolio and quickly stabilized revenues while significantly improving operating margins. Earlier in his career, Green was Regional Vice President of a division of Quest Diagnostics Corporation, Sr. VP & General Manager of Koninklijke Philips Electronics NV Global Computed Tomography Business and held various leadership positions at St. Jude Medical Inc., Beckman Instruments, McDonnell Douglas Corporation and Northrop Advanced Systems. Green earned a bachelor’s degree in electrical engineering from the University of Missouri at Columbia and a master’s degree in computer engineering from the University of Southern California and is a graduate of the Stanford University Executive Program.